The appetite feedback coefficient for tirzepatide (k=48) is marginally lower than semaglutide (k=49), which means the appetite rebound component may be very slightly less aggressive, potentially contributing to a somewhat longer active loss phase in some individuals
Presence of any underlying condition
Therapeutic potential of semaglutide, a newer GLP-1 receptor antagonist in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: a narrative review
That means reaching at least 10mg (ideally 15mg) and staying at that dose for a minimum of 12 weeks before concluding it has failed
"We are pleased the court has rejected the compounders' attempts to undermine FDA's data-based decision that the shortage of Wegovy and Ozempic is resolved," said Steve Benz, Corporate Vice President, Legal and US General Counsel, Novo Nordisk